The dysregulation of S100A8/A9 expression has been associated with severe inflammatory reactions, such as those observed in critical cases of Coronavirus Disease 2019 (COVID-19), especially during the initial stages of infection [82]. The gene discussed is S100A8; the disease is COVID-19.